INTEGER HOLDINGS CORPORATION (ITGR) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-07-03..
Quick ratio
Overview →Financial period ending 2026-07-03; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-07-03. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 217.14M USD | Liabilities, Current |
| Cash and equivalents | 21.38M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 338.73M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 288.06M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-07-03 | (m) | $217.14M | $21.38M | (m) | $338.73M | $288.06M | (m) |
| 2026-04-03 | (m) | $206.34M | $8.12M | (m) | $327.78M | $284.48M | (m) |
| 2025-12-31 | (m) | $232.04M | $17.16M | (m) | $346.08M | $253.74M | (m) |
| 2025-09-26 | (m) | $209.82M | $58.94M | (m) | $310.17M | $263.54M | (m) |
| 2025-06-27 | (m) | $216.03M | $23.14M | (m) | $302.26M | $266.44M | (m) |
| 2025-03-28 | (m) | $206.40M | $31.71M | (m) | $276.24M | $260.10M | (m) |
| 2024-12-31 | (m) | $227.17M | $46.54M | (m) | $245.27M | $247.13M | (m) |
| 2024-09-27 | (m) | $222.40M | $35.57M | (m) | $241.71M | $265.42M | (m) |
| 2024-06-28 | (m) | $205.99M | $34.14M | (m) | $240.50M | $272.33M | (m) |
| 2024-03-29 | (m) | $201.43M | $42.16M | (m) | $237.15M | $262.87M | (m) |
| 2023-12-31 | (m) | $220.97M | $23.67M | (m) | $238.28M | $239.72M | (m) |
| 2023-09-29 | (m) | $203.10M | $32.14M | (m) | $226.33M | $232.16M | (m) |
| 2023-06-30 | (m) | $199.83M | $38.62M | (m) | $236.53M | $228.93M | (m) |
| 2023-03-31 | (m) | $225.47M | $40.60M | (m) | $250.51M | $225.28M | (m) |
| 2022-12-31 | (m) | $223.75M | (m) | (m) | $224.32M | $208.77M | (m) |
| 2022-09-30 | (m) | $198.76M | $20.19M | (m) | $215.98M | $210.46M | (m) |
| 2022-07-01 | (m) | $197.73M | $15.59M | (m) | $221.94M | $194.46M | (m) |
| 2022-04-01 | (m) | $173.08M | $25.67M | (m) | $198.04M | $173.31M | (m) |
| 2021-12-31 | (m) | $159.63M | (m) | (m) | $182.31M | $155.70M | (m) |
| 2021-10-01 | (m) | $156.41M | $25.47M | (m) | $177.49M | $149.24M | (m) |
| 2021-07-02 | (m) | $164.13M | $30.58M | (m) | $175.53M | $147.84M | (m) |
| 2021-04-02 | (m) | $161.55M | $28.40M | (m) | $165.83M | $153.81M | (m) |
| 2020-12-31 | (m) | $156.19M | (m) | (m) | $156.21M | $149.32M | (m) |
| 2020-10-02 | (m) | $153.46M | $99.94M | (m) | $151.20M | $156.86M | (m) |
| 2020-07-03 | (m) | $153.65M | $206.24M | (m) | $147.75M | $172.46M | (m) |
| 2020-04-03 | (m) | $186.13M | $37.26M | (m) | $199.78M | $170.30M | (m) |
| 2019-12-31 | (m) | $179.08M | (m) | (m) | $191.99M | $167.26M | (m) |
| 2019-09-27 | (m) | $188.94M | $14.72M | (m) | $216.67M | $197.98M | (m) |
| 2019-06-28 | (m) | $183.94M | $15.92M | (m) | $217.73M | $187.15M | (m) |
| 2019-03-29 | (m) | $171.50M | $13.54M | (m) | $216.76M | $181.20M | (m) |
| 2018-12-28 | (m) | $164.57M | $25.57M | (m) | $185.50M | $190.08M | (m) |
| 2018-09-28 | (m) | $177.99M | $22.88M | (m) | $200.15M | $193.63M | (m) |
| 2018-06-29 | (m) | $230.38M | $18.86M | (m) | $206.89M | $194.98M | (m) |
| 2018-03-30 | (m) | $224.73M | $29.49M | (m) | $242.22M | $239.49M | (m) |
| 2017-12-29 | (m) | $209.00M | $44.10M | (m) | $242.46M | $227.53M | (m) |
| 2017-09-29 | (m) | $205.07M | $43.64M | (m) | $221.52M | $246.97M | (m) |
| 2017-06-30 | (m) | $195.95M | $46.53M | (m) | $212.61M | $235.56M | (m) |
| 2017-03-31 | (m) | $204.12M | $54.88M | (m) | $213.61M | $231.29M | (m) |
| 2016-12-30 | (m) | $185.22M | $52.12M | (m) | $204.63M | $225.15M | (m) |
| 2016-09-30 | (m) | $199.89M | $44.99M | (m) | $191.41M | $262.23M | (m) |
| 2016-07-01 | (m) | $217.28M | $36.59M | (m) | $192.12M | $276.28M | (m) |
| 2016-04-01 | (m) | $216.51M | $54.12M | (m) | $183.56M | $267.38M | (m) |
| 2016-01-01 | (m) | $213.84M | $82.48M | (m) | $207.34M | $252.17M | (m) |
| 2015-10-02 | (m) | $117.44M | $68.59M | (m) | $108.28M | $164.24M | (m) |
| 2015-07-03 | (m) | $98.63M | $72.34M | (m) | $122.10M | $140.09M | (m) |
| 2015-04-03 | (m) | $87.45M | $67.02M | (m) | $110.43M | $137.99M | (m) |
| 2015-01-02 | (m) | $108.66M | $76.82M | (m) | $124.95M | $129.24M | (m) |
| 2014-10-03 | (m) | $89.96M | $61.58M | (m) | $121.61M | $128.73M | (m) |
| 2014-07-04 | (m) | $78.54M | $51.19M | (m) | $124.56M | $120.61M | (m) |
| 2014-04-04 | (m) | $70.00M | $38.33M | (m) | $117.22M | $118.08M | (m) |
| 2014-01-03 | (m) | $91.80M | $35.47M | (m) | $113.68M | $118.36M | (m) |
| 2013-09-27 | (m) | $91.74M | $4.97M | (m) | $130.97M | $122.82M | (m) |
| 2013-06-28 | (m) | $98.69M | $10.18M | (m) | $138.60M | $122.16M | (m) |
| 2013-03-29 | (m) | $102.56M | $10.14M | (m) | $124.57M | $118.18M | (m) |
| 2012-12-28 | (m) | $91.76M | $20.28M | (m) | $120.92M | $106.61M | (m) |
| 2012-09-28 | (m) | $92.31M | $10.84M | (m) | $124.80M | $111.16M | (m) |
| 2012-06-29 | (m) | $82.20M | $11.13M | (m) | $114.14M | $113.66M | (m) |
| 2012-03-30 | (m) | $78.14M | $9.53M | (m) | $116.37M | $112.45M | (m) |
| 2011-12-30 | (m) | $94.05M | $36.51M | (m) | $101.95M | $109.91M | (m) |
| 2011-09-30 | (m) | $73.78M | $41.63M | (m) | $82.83M | $115.29M | (m) |
| 2011-07-01 | (m) | $75.01M | $36.94M | (m) | $90.45M | $110.07M | (m) |
| 2011-04-01 | (m) | (m) | $51.68M | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | $60.59M | $22.88M | (m) | $70.95M | $101.44M | (m) |
| 2010-10-01 | (m) | (m) | $43.00M | (m) | (m) | (m) | (m) |
| 2010-07-02 | (m) | (m) | $45.66M | (m) | (m) | (m) | (m) |
| 2010-01-01 | (m) | (m) | $37.86M | (m) | (m) | (m) | (m) |
| 2009-01-02 | (m) | (m) | $22.06M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |